Dental: Osteoporosis: Implications for the Oral Healthcare Provider, Updated Edition

9.95
Online
Elective
Please select your state to enroll in this course
About the Course:
This course will address current concepts regarding links between oral health and osteoporosis, discuss the impact on oral health of pharmacotherapies used in the treatment of osteoporosis, and outline steps to mitigate the impact on oral health of drugs commonly used to treat osteoporosis. This intermediate-level course is intended for dental professionals involved in the treatment of patients with and at risk for low bone mass and osteoporosis.

Course Objectives:
1. Describe the etiology and prevalence of osteoporosis.
2. Discuss the putative association between osteoporosis and periodontal disease.
3. Explain the pharmacological treatment of osteoporosis.
4. Describe the oral health implications of medically related jaw necrosis.
5. Identify evidence-based guidelines for the management of bisphosphonate-treated patients.
6. Describe the importance of screening for osteoporosis.

About the Authors: 
Revision AuthorMarc Szarejko, DMD, FAGD received his dental degree from the State University of New York at Buffalo School of Dentistry in 1985 and Fellowship in the Academy of General Dentistry in 1994. He has been an examiner for the State of Florida Dental and Dental Hygiene Licensure Examinations since 1994. He has also served as an expert witness for the State of Florida and for private companies. He has authored and edited many dental continuing education courses and has given presentations on varied dental topics to local, regional, and national audiences. He has served as a dentist in the county correctional system for nearly half of his career, where the incidence of HIV/AIDS is much higher relative to that of the general population. The surgical and nonsurgical dental treatment of HIV/AIDS patients is a common occurrence in this setting, allowing him to have a unique perspective of the oral manifestations of HIV/AIDS patients and in their dental treatment. 
About the 1st edition AuthorJohn F. Kross, DMD, MSc, received his doctor of dental medicine degree from Temple University School of Dentistry in Philadelphia, Pennsylvania. He completed a fellowship at Temple University Hospital in oral oncology and received a hospital appointment to the Department of Dentistry at the Medical Centers of Delaware (now the Christiana Health Care System). His professional training and experience include practicing general dentistry in Wilmington, Delaware, and New London, Pennsylvania, as well as instructing students in oral pathology at Delaware Technical Community College. He has displayed a long-term commitment to contributing to continuing dental education, and has received numerous academic awards for his work in oral surgery, fixed partial prosthodontics, periodontics, and endodontics. He is cofounder of Dental Regulatory Associates, a company specializing in U.S. Food and Drug Administration approval of dental drugs and devices.

AGD code - 730


Course Disclosures

  • Courses must be completed on or before the course expiration date.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Elite ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Elite's policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.
  • There are no prerequisites for this course.
Want Unlimited CE? Become a Member

Osteoporosis: Implications for the Oral Healthcare Provider, Updated Edition

9.95
About the Course:
This course will address current concepts regarding links between oral health and osteoporosis, discuss the impact on oral health of pharmacotherapies used in the treatment of osteoporosis, and outline steps to mitigate the impact on oral health of drugs commonly used to treat osteoporosis. This intermediate-level course is intended for dental professionals involved in the treatment of patients with and at risk for low bone mass and osteoporosis.

Course Objectives:
1. Describe the etiology and prevalence of osteoporosis.
2. Discuss the putative association between osteoporosis and periodontal disease.
3. Explain the pharmacological treatment of osteoporosis.
4. Describe the oral health implications of medically related jaw necrosis.
5. Identify evidence-based guidelines for the management of bisphosphonate-treated patients.
6. Describe the importance of screening for osteoporosis.

About the Authors: 
Revision AuthorMarc Szarejko, DMD, FAGD received his dental degree from the State University of New York at Buffalo School of Dentistry in 1985 and Fellowship in the Academy of General Dentistry in 1994. He has been an examiner for the State of Florida Dental and Dental Hygiene Licensure Examinations since 1994. He has also served as an expert witness for the State of Florida and for private companies. He has authored and edited many dental continuing education courses and has given presentations on varied dental topics to local, regional, and national audiences. He has served as a dentist in the county correctional system for nearly half of his career, where the incidence of HIV/AIDS is much higher relative to that of the general population. The surgical and nonsurgical dental treatment of HIV/AIDS patients is a common occurrence in this setting, allowing him to have a unique perspective of the oral manifestations of HIV/AIDS patients and in their dental treatment. 
About the 1st edition AuthorJohn F. Kross, DMD, MSc, received his doctor of dental medicine degree from Temple University School of Dentistry in Philadelphia, Pennsylvania. He completed a fellowship at Temple University Hospital in oral oncology and received a hospital appointment to the Department of Dentistry at the Medical Centers of Delaware (now the Christiana Health Care System). His professional training and experience include practicing general dentistry in Wilmington, Delaware, and New London, Pennsylvania, as well as instructing students in oral pathology at Delaware Technical Community College. He has displayed a long-term commitment to contributing to continuing dental education, and has received numerous academic awards for his work in oral surgery, fixed partial prosthodontics, periodontics, and endodontics. He is cofounder of Dental Regulatory Associates, a company specializing in U.S. Food and Drug Administration approval of dental drugs and devices.

AGD code - 730


Course Disclosures

  • Courses must be completed on or before the course expiration date.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Elite ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Elite's policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.
  • There are no prerequisites for this course.